TRANSCENDPRP
Live / Applied — Statement of use — registration review complete (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 23 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97690400
- Mark type
- Design + words
- Filed
- 23 Nov 2022
- Published for opposition
- 16 Jan 2024
- Attorney of record
- Vincent J. Allen
Goods and services
- Class 005 — Pharmaceuticals: Blood containers for veterinary and human medical and clinical use sold partially filled with an anticoagulant additive solution
Owner
- Transcend Biologics, LLC, The Colony, TX, US
- Transcend Biologics, LLC, The Colony, TX, US
Prosecution history
- 20 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Sept 2025 — USE AMENDMENT FILED
- 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 2 GRANTED
- 18 Feb 2025 — SOU EXTENSION 2 FILED
- 18 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2024 — SOU EXTENSION 1 GRANTED
- 12 Sept 2024 — SOU EXTENSION 1 FILED
- 12 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT